Real-world data on the effectiveness of brodalumab in patients with moderate-to severe plaque psoriasis in the Greek clinical setting (the BrIDGE study).
Dimitrios RigopoulosEleftheria TampouratziCharalampos AngelakopoulosZoi ApallaIoannis BarkisSophia GeorgiouFlorentina DelliAlexandros DrososEfterpi ZafiriouJohn KatsantonisElisabeth LazaridouPantelis PanagakisEvangelina PapadavidMarkos PapakonstantisAngeliki-Viktoria Roussaki-SchulzeElena SotiriouGeorgios AnastasiadisVasiliki ChasapiKonstantinos SfaelosDemetrios Ioannidesnull nullPublished in: Journal of the European Academy of Dermatology and Venereology : JEADV (2024)
Brodalumab confers rapid and durable responses, as well as improvements in the quality of life of moderate-to-severe psoriasis patients.